ResMed Inc. - stock earnings
RMD Upcoming estimated earnings
| Date | Low Revenue | Average Revenue | High Revenue |
|---|---|---|---|
| April 25, 2024 BeforeMarket | 1.1 billion | 1.2 billion | 1.2 billion |
RMD Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 208.8 million USD | 1.2 billion USD |
| 2023Q3 | 219.4 million USD | 963.0 million USD |
| 2023Q2 | 229.7 million USD | 1.1 billion USD |
| 2023Q1 | 232.5 million USD | 1.1 billion USD |
| 2022Q4 | 224.9 million USD | 1.0 billion USD |
| 2022Q3 | 210.5 million USD | 950.3 million USD |
| 2022Q2 | 195.1 million USD | 914.7 million USD |
| 2022Q1 | 179.0 million USD | 864.5 million USD |
| 2021Q4 | 201.8 million USD | 894.9 million USD |
| 2021Q3 | 203.6 million USD | 904.0 million USD |
| 2021Q2 | 195.1 million USD | 876.1 million USD |
| 2021Q1 | -78.5 million USD | 768.8 million USD |
| 2020Q4 | 179.5 million USD | 800.0 million USD |
| 2020Q3 | 178.4 million USD | 751.9 million USD |
| 2020Q2 | 177.8 million USD | 770.3 million USD |
| 2020Q1 | 163.1 million USD | 769.5 million USD |
| 2019Q4 | 160.6 million USD | 736.2 million USD |
| 2019Q3 | 120.1 million USD | 681.1 million USD |
| 2019Q2 | 68.8 million USD | 705.0 million USD |
| 2019Q1 | 105.4 million USD | 662.2 million USD |
| 2018Q4 | 124.6 million USD | 651.1 million USD |
| 2018Q3 | 105.7 million USD | 588.3 million USD |
| 2018Q2 | 109.8 million USD | 623.6 million USD |
| 2018Q1 | 110.1 million USD | 591.6 million USD |
| 2017Q4 | 9.5 million USD | 601.3 million USD |
| 2017Q3 | 86.1 million USD | 523.7 million USD |
| 2017Q2 | 101.6 million USD | 556.7 million USD |
| 2017Q1 | 87.8 million USD | 514.2 million USD |
| 2016Q4 | 76.7 million USD | 530.4 million USD |
| 2016Q3 | 76.1 million USD | 465.5 million USD |
| 2016Q2 | 83.1 million USD | 518.6 million USD |
| 2016Q1 | 88.5 million USD | 453.9 million USD |
| 2015Q4 | 90.5 million USD | 454.5 million USD |
| 2015Q3 | 80.4 million USD | 411.6 million USD |
| 2015Q2 | 87.5 million USD | 453.1 million USD |
| 2015Q1 | 91.0 million USD | 422.5 million USD |
| 2014Q4 | 91.2 million USD | 423.0 million USD |
| 2014Q3 | 83.3 million USD | 380.4 million USD |
| 2014Q2 | 87.7 million USD | 415.2 million USD |
| 2014Q1 | 90.0 million USD | 397.8 million USD |
| 2013Q4 | 86.6 million USD | 384.3 million USD |
| 2013Q3 | 80.9 million USD | 357.7 million USD |
| 2013Q2 | 73.0 million USD | 414.6 million USD |
| 2013Q1 | 84.9 million USD | 383.6 million USD |
| 2012Q4 | 77.9 million USD | 376.5 million USD |
| 2012Q3 | 71.3 million USD | 339.7 million USD |
| 2012Q2 | 76.8 million USD | 371.9 million USD |
| 2012Q1 | 64.6 million USD | 349.1 million USD |
| 2011Q4 | 62.9 million USD | 332.7 million USD |
| 2011Q3 | 50.5 million USD | 314.8 million USD |
| 2011Q2 | 58.5 million USD | 341.9 million USD |
| 2011Q1 | 168.5 million USD | 901.3 million USD |
| 2010Q4 | 58.5 million USD | 306.0 million USD |
| 2010Q3 | 56.7 million USD | 282.0 million USD |
| 2010Q2 | 53.2 million USD | 291.6 million USD |
| 2010Q1 | 48.8 million USD | 278.7 million USD |
| 2009Q4 | 46.0 million USD | 275.1 million USD |
| 2009Q3 | 42.1 million USD | 247.0 million USD |
| 2009Q2 | 45.4 million USD | 252.0 million USD |
| 2009Q1 | 39.2 million USD | 227.9 million USD |
| 2008Q4 | 33.9 million USD | 223.0 million USD |
| 2008Q3 | 28.0 million USD | 217.9 million USD |
| 2008Q2 | 29.6 million USD | 235.2 million USD |
| 2008Q1 | 29.7 million USD | 211.8 million USD |
| 2007Q4 | 26.9 million USD | 202.7 million USD |
| 2007Q3 | 24.1 million USD | 185.7 million USD |
| 2007Q2 | 27.7 million USD | 191.3 million USD |
| 2007Q1 | -15.4 million USD | 183.0 million USD |
| 2006Q4 | 29.0 million USD | 178.4 million USD |
| 2006Q3 | 25.0 million USD | 163.6 million USD |
| 2006Q2 | 23.1 million USD | 171.2 million USD |
| 2006Q1 | 26.4 million USD | 162.3 million USD |
| 2005Q4 | 22.3 million USD | 146.4 million USD |
| 2005Q3 | 16.4 million USD | 127.1 million USD |
| 2005Q2 | 15.6 million USD | 125.4 million USD |
| 2005Q1 | 17.9 million USD | 108.5 million USD |
| 2004Q4 | 17.4 million USD | 103.9 million USD |
| 2004Q3 | 13.9 million USD | 87.7 million USD |
| 2004Q2 | 15.9 million USD | 92.9 million USD |
| 2004Q1 | 15.0 million USD | 91.3 million USD |
| 2003Q4 | 14.2 million USD | 82.3 million USD |
| 2003Q3 | 12.2 million USD | 72.9 million USD |
| 2003Q2 | 13.5 million USD | 80.7 million USD |
| 2003Q1 | 12.3 million USD | 69.0 million USD |
| 2002Q4 | 10.4 million USD | 65.3 million USD |
| 2002Q3 | 9.6 million USD | 58.6 million USD |
| 2002Q2 | 9.8 million USD | 56.2 million USD |
| 2002Q1 | 10.4 million USD | 52.8 million USD |
| 2001Q4 | 8.8 million USD | 48.9 million USD |
| 2001Q3 | 8.5 million USD | 46.1 million USD |
| 2001Q2 | 8.3 million USD | 47.0 million USD |
| 2001Q1 | -10.2 million USD | 42.7 million USD |
| 2000Q4 | 6.9 million USD | 34.4 million USD |
| 2000Q3 | 6.6 million USD | 31.1 million USD |
| 2000Q2 | 6.2 million USD | 31.6 million USD |
| 2000Q1 | 5.8 million USD | 30.0 million USD |
| 1999Q4 | 5.4 million USD | 28.1 million USD |
| 1999Q3 | 4.8 million USD | 25.9 million USD |
| 1999Q2 | 4.6 million USD | 25.1 million USD |
| 1999Q1 | 4.4 million USD | 22.8 million USD |
| 1998Q4 | 3.9 million USD | 21.5 million USD |
| 1998Q3 | 3.2 million USD | 19.2 million USD |
| 1998Q2 | 3.0 million USD | 19.3 million USD |
| 1998Q1 | 3.1 million USD | 17.1 million USD |
| 1997Q4 | 2.3 million USD | 16.1 million USD |
| 1997Q3 | 2.2 million USD | 14.0 million USD |
| 1997Q2 | 2.1 million USD | 14.0 million USD |
| 1997Q1 | 1.9 million USD | 12.5 million USD |
| 1996Q4 | 1.7 million USD | 11.6 million USD |
| 1996Q3 | 1.8 million USD | 11.1 million USD |
| 1996Q2 | 1.5 million USD | 10.6 million USD |
| 1996Q1 | 1.2 million USD | 9.4 million USD |
| 1995Q4 | 900000 USD | 7.9 million USD |
| 1995Q3 | 900000 USD | 6.7 million USD |
| 1995Q2 | 700000 USD | 6.7 million USD |
| 1995Q1 | 700000 USD | 5.6 million USD |
| 1994Q4 | 700000 USD | 5.6 million USD |
| 1994Q3 | 700000 USD | 5.6 million USD |
| 1994Q2 | 300000 USD | 3.4 million USD |
| 1994Q1 | 300000 USD | 3.5 million USD |
| 1993Q4 | 300000 USD | 3.5 million USD |
| 1993Q3 | 300000 USD | 3.5 million USD |
| 1993Q2 | 200000 USD | 2.0 million USD |
| 1993Q1 | 200000 USD | 1.9 million USD |
| 1992Q4 | 200000 USD | 1.9 million USD |
| 1992Q3 | 200000 USD | 1.9 million USD |
RMD Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 897.6 million USD | 4.2 billion USD |
| 2022 | 779.4 million USD | 3.6 billion USD |
| 2021 | 474.5 million USD | 3.2 billion USD |
| 2020 | 621.7 million USD | 3.0 billion USD |
| 2019 | 404.6 million USD | 2.6 billion USD |
| 2018 | 315.6 million USD | 2.3 billion USD |
| 2017 | 342.3 million USD | 2.1 billion USD |
| 2016 | 352.4 million USD | 1.8 billion USD |
| 2015 | 352.9 million USD | 1.7 billion USD |
| 2014 | 345.3 million USD | 1.6 billion USD |
| 2013 | 307.1 million USD | 1.5 billion USD |
| 2012 | 254.9 million USD | 1.4 billion USD |
| 2011 | 227.0 million USD | 1.2 billion USD |
| 2010 | 190.1 million USD | 1.1 billion USD |
| 2009 | 146.4 million USD | 920.7 million USD |
| 2008 | 110.3 million USD | 835.4 million USD |
| 2007 | 66.3 million USD | 716.3 million USD |
| 2006 | 88.2 million USD | 607.0 million USD |
| 2005 | 64.8 million USD | 425.5 million USD |
| 2004 | 57.3 million USD | 339.3 million USD |
| 2003 | 45.7 million USD | 273.6 million USD |
| 2002 | 37.5 million USD | 204.1 million USD |
| 2001 | 11.6 million USD | 155.2 million USD |
| 2000 | 22.2 million USD | 115.6 million USD |
| 1999 | 16.1 million USD | 88.6 million USD |
| 1998 | 10.6 million USD | 66.5 million USD |
| 1997 | 7.5 million USD | 49.2 million USD |
| 1996 | 4.5 million USD | 34.6 million USD |
| 1995 | 2.8 million USD | 23.5 million USD |
| 1994 | 1.2 million USD | 13.9 million USD |
| 1993 | 800000 USD | 7.7 million USD |
RMD
List: Contenders
Price: $184.23
52 week price:
Dividend Yield: 0.01%
5-year range yield:
Forward Dividend Yield: 1.04%
Payout Ratio: 31.74%
Payout Ratio Range:
Dividend Per Share: 1.92 USD
Earnings Per Share: 6.05 USD
P/E Ratio: 30.52
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 1.2 million
Ebitda: 178.5 millionMarket Capitalization: 27.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 13
DGR3: 4.17%
DGR5: 4.76%
DGR10: 7.43%